成人噬血细胞性淋巴组织细胞增多症患者出血与血栓栓塞的发生率及其对总生存的影响:一项20年省级回顾性队列研究
该多中心回顾性队列研究纳入加拿大阿尔伯塔省1999至2019年97例成人噬血细胞性淋巴组织细胞增多症(HLH)患者,评估出血与血栓栓塞的累积发生率及对总生存(OS)的影响。静脉血栓栓塞(VTE)发生于11例(11%)患者,中位时间为入院后9天;ISTH大出血和临床相关非大出血发生于39例(40%)患者,中位时间为入院后16天。校正竞争风险后,90天出血和血栓栓塞累积发生率分别为39%和13%;中位OS为18.8个月;VTE(而非出血)与不良OS显著相关(校正风险比2.5,95%CI 1.1-5.7)。
要点
- 成人HLH患者VTE发生率为11%,中位发生于入院后9天。
- ISTH大出血和临床相关非大出血发生率为40%,中位发生于入院后16天。
- 校正竞争风险后90天出血和血栓栓塞累积发生率分别为39%和13%。
核心结论
- 在成人HLH患者中,VTE似乎比既往描述的更常见,并且是死亡的预测因素,但这可能由于未校正的混杂因素所致。
- 由于出血率高,VTE的预防和治疗具有挑战性。
研究设计与样本
- 研究为多中心回顾性队列研究,纳入加拿大阿尔伯塔省1999至2019年97例成人HLH患者,中位年龄46岁。
- 计算出血和血栓栓塞的累积发生率时考虑了竞争风险,并使用Cox比例风险模型评估其对总生存(OS)的影响。
主要发现
- 静脉血栓栓塞(VTE)发生于11例(11%)患者,中位时间为入院后9天。
- ISTH大出血和临床相关非大出血发生于39例(40%)患者,中位时间为入院后16天。
- 多变量分析显示,最低血小板计数(每对数下降校正比值比[aOR] 1.8,95%CI 1.2-2.8)和机械通气(aOR 4.9,95%CI 1.8-14.8)是出血的独立预测因素。
- 校正竞争风险后,90天出血和血栓栓塞的累积发生率分别为39%和13%。
- 中位OS为18.8个月;VTE与不良OS显著相关(校正风险比2.5,95%CI 1.1-5.7),而出血与OS无显著关联。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Hemophagocytic lymphohistiocytosis (HLH) is a rare syndrome characterized by uncontrolled immune activation and high risk of death. There is scarce data on the incidence of bleeding and thromboembolism in HLH. OBJECTIVES: To determine the cumulative incidence of bleeding and thromboembolism and impact on survival in adults with HLH. PATIENTS/METHODS: We conducted a multicenter retrospective cohort study of adults with HLH in Alberta, Canada (1999-2019). The cumulative incidence of bleeding and thromboembolism were calculated, accounting for competing risks. Cox proportional hazards models were used to assess the impact of bleeding and thromboembolism on overall survival (OS). RESULTS: We identified 97 adults with HLH (median age 46 years). Venous thromboembolism (VTE) occurred in 11 (11%) patients at a median of 9 days from admission. ISTH major bleeding and clinically relevant non-major bleeding occurred in 39 (40%) patients, at a median of 16 days after admission. Nadir platelet count (adjusted odds ratio [aOR] 1.8 per log decrease, 95% confidence interval [CI] 1.2-2.8) and mechanical ventilation (aOR 4.9, 95% CI 1.8-14.8) were independent predictors of bleeding on multivariable analysis. Adjusting for competing risks, the 90-day cumulative incidences of bleeding and thromboembolism were 39% and 13%, respectively. The median OS was 18.8 months. VTE, but not bleeding, was significantly associated with adverse OS (adjusted hazard ratio 2.5, 95% CI 1.1-5.7). CONCLUSIONS: In adults with HLH, VTE appears more common than previously described and is a predictor of mortality, although this may be due to unadjusted confounding. VTE prevention and treatment are challenging due to high bleeding rates.
引用
- Croden J, Bilston L, Taparia M, et al. Incidence of bleeding and thromboembolism and impact on overall survival in adult patients with hemophagocytic lymphohistiocytosis: A 20-year provincial retrospective cohort study. J Thromb Haemost. 2021. PMID: 34856055. doi:10.1111/jth.15615
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。